GovIntel / WA / BONUM THERAPEUTICS, INC.

BONUM THERAPEUTICS, INC.

Government contractor · Seattle, WA

UEIRAS1PPLP28B2
CAGE14EA3
SizeSmall business
SAM statusActive
Established2021

About BONUM THERAPEUTICS, INC.

Bonum Therapeutics is a biotechnology company focused on developing antibody-controlled therapeutics that are only active when bound to a target molecule, with applications in oncology, autoimmunity, metabolic disorders, and pain management. The company was formed following the acquisition of its predecessor, Good Therapeutics, by Roche in 2022.

Development of antibody-controlled therapeuticsCreation of regulated protein therapeutics with localized activityEngineering sensor domains to target peptides, proteins, and metabolitesDesign of cytokine-based therapeutics for cancer treatmentExploration of applications in autoimmune disease, metabolic disorders, and pain management

Is this your company?

Claim BONUM THERAPEUTICS, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim BONUM THERAPEUTICS, INC. & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.